title: Sepsis pathophysiology and anesthetic consideration.
abstract: Sepsis remains to be a significant health care issue associated with high mortality and healthcare cost, despite the extensive effort to better understand the pathophysiology of the sepsis. Recently updated clinical guideline for severe sepsis and septic shock, "Surviving Sepsis Campaign 2012", emphasizes the importance of early goal-directed therapy, which can be implemented in intraoperative management of sepsis patients. Herein, we review the updates of current guideline and discuss its application to anesthesic management. Furthermore, we review the recent advance in knowledge of sepsis pathophysiology, focusing on immune modulation, which may lead to new clinical therapeutic approach to sepsis.
authors.forename: Koichi
authors.initials: K
authors.lastname: Yuki
authors.affiliation: Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, Massachusetts, 02115, USA.
authors.forename: Naoka
authors.initials: N
authors.lastname: Murakami
mesh_terms: D000777:Anesthetics / Q000008:administration & dosage*; D000818:Animals; D006801:Humans; D017410:Practice Guidelines as Topic; D018805:Sepsis / Q000276:immunology / Q000503:physiopathology* / Q000628:therapy; D012720:Severity of Illness Index; D012772:Shock, Septic / Q000276:immunology / Q000503:physiopathology* / Q000628:therapy
chemical_list: D000777:Anesthetics